Literature DB >> 35294702

Screening of OTULIN gene mutation with targeted next generation sequencing in Turkish populations and in silico analysis of these mutations.

Yüksel Gezgin1, Berkay Kırnaz2, Afig Berdeli2,3.   

Abstract

BACKGROUND: OTULIN-related autoinflammatory syndrome (ORAS) is an autosomal recessive disease characterized by systemic inflammation, recurrent fever. Due to limited knowledge about the OTULIN DNA variants that cause ORAS, the diagnosis and treatment of this disease is difficult. In this study, we aim to identify OTULIN DNA variants responsible for the genetic pathology of ORAS and observe the effects of these variants on the OTULIN protein structure and the function with different bioinformatics approaches.
METHODS: The present study included 3230 individuals with the suspicion of an autoinflammatory disease who were referred to Ege University Children's Hospital Molecular Medicine Laboratory. OTULIN variants were detected using a panel consisting of 37 different autoinflammatory diseases (AID) genes via targeted Next-Generation Sequencing.
RESULTS: As a result of the study, DNA variants associated with various AID were detected in 65% of the individuals to whom the panel was applied. Among these variants, only three different OTULIN variants (p.Val82Ile, p.Gln115His and p.Leu131_Arg132insLeuCysThrGlu) were detected. The pathogenic effects of the variants detected in the OTULIN gene were determined by using Polyphen2 as "Probably Pathogenic" for the p.Val82Ile and "benign" for the p.Gln115His. At the same time, the effects of these variants on the structure and function of the OTULIN protein were investigated by in silico approaches. Both variants reduce protein stability and binding affinity.
CONCLUSION: The results of the current study suggest that the evaluation of OTULIN variants with in silico approaches will contribute to the development of personalized treatments by diagnosing the disease specific to the variant.
© 2022. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  In silico analysis; Next generation sequencing; ORAS; OTULIN gene; Rare autoinflammatory disease

Mesh:

Substances:

Year:  2022        PMID: 35294702     DOI: 10.1007/s11033-022-07312-5

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.742


  23 in total

Review 1.  Ubiquitin: structures, functions, mechanisms.

Authors:  Cecile M Pickart; Michael J Eddins
Journal:  Biochim Biophys Acta       Date:  2004-11-29

Review 2.  Molecular mechanisms of phenotypic variability in monogenic autoinflammatory diseases.

Authors:  Ivona Aksentijevich; Oskar Schnappauf
Journal:  Nat Rev Rheumatol       Date:  2021-05-25       Impact factor: 20.543

Review 3.  OTULIN in NF-κB signaling, cell death, and disease.

Authors:  Lien Verboom; Esther Hoste; Geert van Loo
Journal:  Trends Immunol       Date:  2021-05-29       Impact factor: 16.687

Review 4.  The Met1-Linked Ubiquitin Machinery: Emerging Themes of (De)regulation.

Authors:  Matous Hrdinka; Mads Gyrd-Hansen
Journal:  Mol Cell       Date:  2017-10-19       Impact factor: 17.970

Review 5.  Inflammasomes in the pathophysiology of autoinflammatory syndromes.

Authors:  Sarang Tartey; Thirumala-Devi Kanneganti
Journal:  J Leukoc Biol       Date:  2019-10-14       Impact factor: 4.962

6.  Biallelic hypomorphic mutations in a linear deubiquitinase define otulipenia, an early-onset autoinflammatory disease.

Authors:  Qing Zhou; Xiaomin Yu; Erkan Demirkaya; Natalie Deuitch; Deborah Stone; Wanxia Li Tsai; Hye Sun Kuehn; Hongying Wang; Dan Yang; Yong Hwan Park; Amanda K Ombrello; Mary Blake; Tina Romeo; Elaine F Remmers; Jae Jin Chae; James C Mullikin; Ferhat Güzel; Joshua D Milner; Manfred Boehm; Sergio D Rosenzweig; Massimo Gadina; Steven B Welch; Seza Özen; Rezan Topaloglu; Mario Abinun; Daniel L Kastner; Ivona Aksentijevich
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-24       Impact factor: 11.205

7.  Next-generation sequencing and its initial applications for molecular diagnosis of systemic auto-inflammatory diseases.

Authors:  Marta Rusmini; Silvia Federici; Francesco Caroli; Alice Grossi; Maurizia Baldi; Laura Obici; Antonella Insalaco; Alberto Tommasini; Roberta Caorsi; Eleonora Gallo; Alma Nunzia Olivieri; AngeloValerio Marzano; Domenico Coviello; Roberto Ravazzolo; Alberto Martini; Marco Gattorno; Isabella Ceccherini
Journal:  Ann Rheum Dis       Date:  2015-09-17       Impact factor: 19.103

8.  OTULIN antagonizes LUBAC signaling by specifically hydrolyzing Met1-linked polyubiquitin.

Authors:  Kirstin Keusekotten; Paul Ronald Elliott; Laura Glockner; Berthe Katrine Fiil; Rune Busk Damgaard; Yogesh Kulathu; Tobias Wauer; Manuela Kathrin Hospenthal; Mads Gyrd-Hansen; Daniel Krappmann; Kay Hofmann; David Komander
Journal:  Cell       Date:  2013-06-06       Impact factor: 41.582

Review 9.  Systemic autoinflammatory diseases.

Authors:  Julie Krainer; Sandra Siebenhandl; Andreas Weinhäusel
Journal:  J Autoimmun       Date:  2020-02-01       Impact factor: 7.094

10.  The Deubiquitinase OTULIN Is an Essential Negative Regulator of Inflammation and Autoimmunity.

Authors:  Rune Busk Damgaard; Jennifer A Walker; Paola Marco-Casanova; Neil V Morgan; Hannah L Titheradge; Paul R Elliott; Duncan McHale; Eamonn R Maher; Andrew N J McKenzie; David Komander
Journal:  Cell       Date:  2016-08-11       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.